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Human islets isolated for transplantation are exposed to multiple stresses including oxidative stress and hypoxia resulting in
signiﬁcant loss of functional β cell mass. In this study we examined the modulation of apoptosis pathway genes in islets exposed to
hydrogen peroxide, peroxynitrite, hypoxia, and cytokines. We observed parallel induction of pro- and antiapoptotic pathways and
identiﬁed several novel genes including BFAR, CARD8, BNIP3, and CIDE-A. As BNIP3 is an inducer of autophagy, we examined
thispathwayinMIN6cells,amousebetacelllineandinhumanislets.CultureofMIN6cellsunderlowserumconditionsincreased
the levels of several proteins in autophagy pathway, including ATG4, Beclin 1, LAMP-2, and UVRAG. Amino acid deprivation led
to induction of autophagy in human islets. Preconditioning of islets with inducers of autophagy protected them from hypoxia-
induced apoptosis. However, induction of autophagy during hypoxia exacerbated apoptotic cell death. ER stress led to induction
of autophagy and apoptosis in β cells. Overexpression of MnSOD, an enzyme that scavenges free radicals, resulted in protection of
MIN6cellsfromcytokine-inducedapoptosis.Ceramide,amediatorofcytokine-inducedinjury,reducedtheactivephosphorylated
form of Akt and downregulated the promoter activity of the antiapoptotic gene bcl-2. Furthermore, cytokine-stimulated JNK
pathway downregulated the bcl-2 promoter activity which was reversed by preincubation with SP600125, a JNK inhibitor. Our
ﬁndings suggest that β cell apoptosis by multiple stresses in islets isolated for transplantation is the result of orchestrated gene
expression in apoptosis pathway.
1.Introduction
The major pathways of apoptosis are the extrinsic pathway,
initiated by Fas and other death receptors resulting in the
activation of caspase-8, and the intrinsic mitochondrial
pathway, regulated by Bcl-2 family of proteins leading to the
activation of caspase-9 [1, 2]. These two pathways converge
with the activation of caspase-3. Both apoptotic pathways
are involved in β cell death in type 1 and type 2 diabetes
[3]. Fas (CD95/APO-1) is a 36-kD death receptor protein
that initiates apoptosis in many cell types when cross-linked
to Fas ligand (FasL/CD95L) [4]. A histological study of
human diabetic pancreas biopsies has demonstrated Fas
expression on β cells and FasL expression on the inﬁltrating
cells [5]. However, the intrinsic mitochondrial pathway,
regulated by the Bcl-2 family of proteins, consisting of
proapoptotic (Bax and Bak1) and antiapoptotic (Bcl-2, Bcl-
x L ,M c l - 1 ,e t c . )p r o t e i n s[ 6], has been shown to play a
predominant role in the loss of isolated islets [7]. Imbalance
between these two groups of proteins results in the release
of cytochrome c, which activates caspase-9 [2]. BH3-only
proteins, a subset of proapoptotic proteins, act as sensors
of cellular stress [8, 9]. Members of this family include
Bad, Bid, Bmf, Hrk, Bim, Bik, Noxa, and Puma. They
induce apoptosis by activating proapoptotic proteins or by
neutralizing antiapoptotic proteins. Bid cleaved by caspase-
8 translocates to mitochondria and causes cytochrome c
release, thus linking the two pathways of apoptosis [10].
Autophagy is a lysosomal degradative pathway that
provides energy through self-digestion under conditions of
starvation. During oxidative stress, autophagy serves as a
defense mechanism to clear oxidatively damaged proteins2 Experimental Diabetes Research
and organelles [11] .T h e r ea r et h r e em a j o rp a t h w a y so f
autophagy: (1) chaperone-mediated autophagy (CMA),
which is found in mammalian cells alone and degrades
cytosolic proteins selectively; (2) microautophagy, whereby
lysosomes directly engulf cytosolic constituents through
invaginations of the lysosomal membrane; and (3) macroau-
tophagy (referred to as autophagy), in which cytosolic
contents including organelles and proteins are sequestered
within double-membrane structures called autophagosomes
that fuse with lysosomes and lead to degradation. A series
of maturation steps involving the ATG family of proteins are
involved in the formation of autophagosomes. Among the
30 ATG genes identiﬁed in yeast, 11 (ATG1, 3–10, 12, and
16) have orthologs in mammalian cells. Autophagic vesicles
contain multiple proteins, including Type (or Class) III PI3
kinase (vps34), Beclin 1 (ATG6), UVRAG, and Ambra. An
important step in the formation of autophagosomes is the
conjugation of LC3 (ATG8) with phosphatidylethoanlamine
to form LC3-PE (LC3-II) which is a standard marker for
autophagy. Extensive autophagy could lead to type 2 cell
death, a second mode of programmed cell death [12].
Aged insulin-secreting granules in β cells are degraded by
crinophagy [13]. An imbalance between insulin production
and secretion, which is likely to occur in type 2 diabetes,
induces autophagy to degrade accumulated insulin granules
[14]. Ubiquitinated protein aggregates that accumulate in
β cells of islets in obese Zucker rats have been shown to
stimulate autophagy [15]. Increased autophagic activity has
been observed in the islets of Rab3A−/− mice which display a
defect in insulin secretion [13].
Islets are clusters of diﬀerent cell types including α,
β, δ, and PP cells, with insulin-producing β cells being
the major component (70–80%). The blood vessels inside
islets are essential for the supply of oxygen, nutrients, and
secretion of hormones. These vessels are disrupted during
theisletisolationprocess.Thus,isletsarevulnerabletoinjury
in the early stages after transplantation due to the delay
in revascularization [16]. Even after revascularization, the
vascular density is considerably less compared to endoge-
nous islets [17]. The expression of genes associated with
angiogenesis is decreased in diabetic transplant recipients,
further delaying the revascularization process [18]. The
molecular mechanism of apoptosis in β cells of islets in
the transplantation setting is not clearly understood. The
objective of the present study was to proﬁle the expression of
apoptosis pathway genes in human islets exposed to stresses
associated with islet isolation and transplantation and to
determine the role of stress-signaling pathways.
2.ExperimentalProcedures
2.1. Culture of Human Islets and MIN6 Cells. Human islets
isolated from cadaveric donors were provided by Integrated
Islet Distribution Program (IIDP). Islets with purity of 70%
to 95% and the viability of 70%–95% were used. Islets were
cultured in CMRL 1066 medium (Mediatech Inc., Hendon,
VA) supplemented with human serum albumin (0.5%;
Octapharma, Vienna, Austria) and nicotinamide (10mM)
and referred to as Miami medium. To induce hypoxia in
islets,culturedisheswereplacedinsideamodularincubation
chamber (Billups Rothenberg, Del Mar, CA) and ﬂushed
with a gas supply of 1% oxygen, 5% CO2, and 94% N2
for 20min. The chamber was then placed inside the cell
culture incubator. MIN6 cells, a mouse pancreatic β cell
line [19], obtained from Dr. Miyazaki (Kyoto University,
Japan) were cultured in RPMI medium containing 10% FBS
(Gemini Bioproducts, Sacramento, CA), 100μg/mL strepto-
mycin (Gemini Bioproducts), 100U/mL penicillin (Gemini
Bioproducts), and 50μM β-mercaptoethanol (BME; Sigma
Aldrich, St. Louis, MO) at 37◦C in a humidiﬁed atmosphere
of 5% CO2. Autophagy was induced in MIN6 cells by
culturing them in low serum (0.1%) serum-containing
medium and in human islets by amino acid deprivation.
2.2. Gene Expression Proﬁling of Apoptosis Pathways. Human
islets isolated from donor pancreas were exposed to Hydro-
gen peroxide, peroxynitrite, hypoxia, or a combination of
cytokines (IL-1β,T N F - α,a n dI F N - γ). A pathway-speciﬁc,
PCR-based array (SABioscience, Frederick, MD) was per-
formed to determine the expression of a panel of genes
in apoptosis pathway (listed in Table 1). RNA samples
following DNase treatment were converted to cDNA by the
following procedure: 1μg of RNA was reverse transcribed
in a 50μL reaction mixture with 125U of Moloney Murine
leukemia virus reverse transcriptase, 20U RNasin ribonu-
clease inhibitor, 4mM deoxyribonucleoside triphosphates,
5mM MgCl 2,1 XP C RB u ﬀer II, and 0.5μgo fr a n d o m
hexanucleotide primers (Applied Biosystems, Carlsbad, CA).
The reaction mixture was sequentially incubated at 65◦C
for 5min, 42◦C for 60min, and the reverse transcription
reaction was stopped by heating to 95◦Cf o r5 m i na n d
cooled to 4◦C. The experimental cocktail was prepared by
adding 102μL of the diluted cDNA to 1278μL of the RT
2
qPCR master mix containing SYBR Green (SA Biosciences,
Frederick, MD) and 1173μLH 2O. 25 μL of this cocktail
was added to each well of the 96-well PCR array plate
containing primers for the 84 genes in apoptotic pathway,
ﬁve housekeeping control genes, and three RNA and PCR
quality controls. Real-time PCR was performed in an ABI
Prism 7700 sequence detector (Applied Biosystems, Foster
City, CA). The thermal cycling conditions were 1 cycle of 10
minutes at 95◦C followed by 40 cycles of 15 seconds at 95◦C
and of 1 minute at 60◦C. After ampliﬁcation, real-time data
acquisition and analysis were performed through the Data
Analysis Web Portal (SA Biosciences). Data analysis is based
on the delta-delta Ct method with normalization of the raw
data to GAPDH as described in the manufacturer’s manual.
2.3. RNA Isolation and Real-Time Quantitative RT-PCR.
Total RNA was isolated from treated islets. After DNAse
treatment, RNA integrity was determined by capillary elec-
trophoresis using RNA 6000 Nano LabChip. The mRNA
levelsofselectedgenes(BFAR,CARD8,CIDE-A,andBNIP3)
identiﬁed in the expression proﬁling described previously
were examined by real-time quantitative RT-PCR using
Taqmanprobes. Assay on Demand (Applied Biosystems) wasExperimental Diabetes Research 3
used for BNIP3. The sequence for primers and probes for
other targets is as follows:
BFAR
Forward Primer: GGAGGACATCGTCACCAAGC
Reverse Primer: AGTATTTGACCAGGAACTCTCT
CCA
TaqMan Probe: 5 -6FAM-TCTGGATCTTAAGGAG
CCTACGTGGAAGCA-TAMRA-3 
CARD8
Forward Primer: GACTTCCGGTCGCCATGAT
Reverse Primer: ACCATTGAAGATGGCCCAGA
TaqMan Probe: 5 -6FAM-TGGGCGGTAAACGCG
GTTAGTGC-TAMRA-3 
CIDE-A
Forward Primer: TCTTTCAGACCTTGGGAGACA
AC
Reverse Primer: TGGCTGCCCGGCATC
TaqMan Probe: 5 -6FAM-CGCATTTCATGATCTT
GGAAAAAGGACAGA-TAMRA-3 .
The PCR reactions were monitored in real time in an ABI
Prism 7700 sequence detector (Perkin Elmer Corp./Applied
Biosystems). After ampliﬁcation, real-time data acquisition
and analysis were performed.
2.4. Western Blot Analysis. MIN6 cells and human islets
exposed to stress conditions were washed with ice-cold PBS
and lysed with mammalian protein extraction reagent (M-
PER, Pierce, Rockford, Illinois, USA) supplemented with
phosphatase inhibitors (20mM of sodium ﬂuoride, 1mM
of sodium orthovanadate and 500nM of okadaic acid) and
protease inhibitors (Sigma P8340). Lysates were centrifuged
at 20,800×g, and the protein concentration was determined
in the supernatant samples by a dye-binding method [20].
Diluted samples containing equal amounts of protein were
mixed with 2X Laemmli sample buﬀer. The proteins were
resolved on a 12% SDS-polyacrylamide gels. Following
transfer to PVDF membranes (Millipore, Bedford, MA), the
blots were blocked with TBST (20mM Tris-HCl (pH 7.9),
8.5% NaCl, and 0.1% Tween 20) containing 5% non-fat
dry milk at room temperature (RT) for 1h and exposed to
primary antibodies (1:1000; Cell Signaling, Danvers, MA)
in TBST containing 5.0% BSA at 4◦C overnight. The blots
were washed with TBST and anti-rabbit IgG conjugated to
alkalinephosphatase(CellSignaling)wasaddedforonehour
at RT. After incubation in the presence of alkaline buﬀer
(10mM Tris-HCl (pH 9.5), 10mM, NaCl and 1mM MgCl2),
signals were developed with CDP-Star reagent (New England
Biolabs, Beverly, MA) and exposed to X-ray ﬁlm. The
intensity of bands was measured using Fluor-S MultiImager
and Quantity One software from Bio-Rad.
2.5. Transfection Procedure. The activity of bcl-2 promoter
(truncated with CRE site, −1640–1287) linked to ﬁreﬂy
luciferase reporter gene (provided by Linda Boxer, Stan-
ford University School of Medicine) was measured in
cultured MIN6 cells by a transient transfection assay using
the procedure described earlier [21]. Plasmids (2μg) and
LipofectAMINE reagent 2000 (Invitrogen-Life Technologies,
Carlsbad, CA) (4μL) were diluted separately in 100μLo f
Opti-MEM I, mixed, and incubated at room temperature for
20min. A constitutively active renilla luciferase (pRL-TK-
luc) was included to correct for transfection eﬃciency and
for nonspeciﬁc actions of treatments on luciferase activity.
The plasmid mixture were added to MIN6 cells cultured
in 12 well dishes to about 70% conﬂuence. The transfected
MIN6 cells were cultured in low serum (0.1%) medium
with appropriate treatment. The treated cells were washed
with cold PBS and lysed with 100μLo fr e p o r t e rl y s i sb u ﬀer.
The lysate was centrifuged (10,600×g; 20min) to collect the
supernatant. The activities of ﬁreﬂy luciferase and renilla
luciferase were measured using a dual luciferase assay kit
(Promega, Madison, WI). The ratios of these two luciferase
activities were taken as the measure of bcl-2 promoter
induction.
2.6. Immunocytochemistry. MIN6 cells were cultured in a
Lab-Tek II Chamber Slide system; following transfection
and treatment, they were ﬁxed in 4% paraformaldehyde
for 30 minutes at RT. After washing with PBS, ﬁxed cells
were permeabilized in PBS containing 0.2% Triton X-100
and 5% BSA for 90 minutes. The cells were incubated in
the presence of antibodies for active caspase-9 or active
caspase-3 (1:250) in 3% BSA at 4◦C overnight, washed
in PBS, and exposed to secondary antibodies linked to
Cy3 (Jackson ImmunoResearch Laboratories, West Grove,
Pennsylvania, USA) in 3% BSA for 90 minutes at RT. Cells
were then washed in PBS, sealed with mounting medium
and examined by digital deconvolution microscopy using a
Zeiss Axioplan 2 microscope ﬁtted with Cooke SensiCamQE
highperformanceCCDcamera.Immunocytochemistrywith
islets was carried out by a similar procedure but with islets
in suspension. Primary antibodies were at the dilution of
1:2000forinsulinand1:500forLC3-IIandphosphorylated
Akt.AppropriatesecondaryantibodieslinkedtoCy3orFITC
in 3% BSA were used. Washing steps were performed by
centrifugation at 500RPM for 5min. After the ﬁnal step
of washing the ﬂuorescent labeled islets in PBS, they were
suspended in mounting medium and placed inside secure
seal hybridization chambers for ﬂuorescent microscopy.
Images were taken in multiple z-planes and assembled
together by digital deconvolution microscopy.
Statistical analysis was performed by one-way analysis of
variance (ANOVA) with Dunnett’s multiple comparison test.
3. Results
3.1.GeneExpressionProﬁlingofApoptosisPathwaysinHuman
Islets under Stress. We performed an apoptosis pathway-
speciﬁc gene expression array with RNA isolated from4 Experimental Diabetes Research
Table 1: Functional grouping of apoptosis pathway genes.
Bcl-2 family BAD, BAG1, BAG3, BAG4, BAK1, BAX, BCL2, BCL2A1, BCL2L1, BCL2L10, BCL2L11, BCL2L2,
BCLAF1, BID, BIK, BNIP1, BNIP2, BNIP3, BNIP3L, HRK, MCL1
Caspase family CASP1, CASP10, CASP14, CASP2, CASP3, CASP4, CASP5, CASP6, CASP7, CASP8, CASP9
IAP family BIRC1, BIRC2, BIRC3, BIRC4, BIRC6, BIRC8
TRAF family TRAF2, TRAF3, TRAF4
CARD family APAF1, BCL10, BIRC2, BIRC3, CARD4, CARD6, CARD8, CASP1, CASP2, CASP4, CASP5, CASP9,
CRADD, NOL3, PYCARD, RIPK2
Death domain family CRADD, DAPK1, FADD, FAS (TNFRSF6), TNFRSF10A, TNFRSF10B, TNFRSF11B, TNFRSF1A,
TNFRSF21, TNFRSF25, TRADD
Death eﬀector domain family CASP8, CASP10, CFLAR, FADD
CIDE domain family CIDE-A, CIDE-B, DFFA
p53 and DNA damage response ABL1, AKT1, APAF1, BAD, BAX, BCL2, BCL2L1, BID, CASP3, CASP6, CASP7, CASP9, GADD45A,
TP53, TP53BP2, TP73
Anti-apoptosis AKT1, BAG1, BAG3, BCL2, BCL2A1, BCL2L1, BCL2L10, BCL2L2, BFAR, BIRC1, BIRC2, BIRC3,
BIRC4, BIRC6, BIRC8, BNIP1, BNIP2, BNIP3, BRAF, CFLAR, IGF1R, MCL1, TNFRSF7
TNF ligand family CD40LG (TNFSF5), FASLG (TNFSF6), LTA, TNF, TNFSF10, TNFSF7, TNFSF8
TNF receptor family CD40 (TNFRSF5), FAS (TNFRSF6), LTBR, TNFRSF10A, TNFRSF10B, TNFRSF11B, TNFRSF1A,
TNFRSF1B, TNFRSF21, TNFRSF25, TNFRSF7, TNFRSF9
Table 2: Mean fold (>2.0) changes in apoptosis pathway gene expression in islets after exposure to oxidative stress (H2O2 and peroxynitrite),
hypoxia, and cytokines.
Genes Role in apoptosis Peroxynitrite H2O2 Hypoxia Cytokines
Bcl2A1 Anti-apoptotic; Bcl2 family 3.2 2.1 2.4 11.4
Bid Proapoptotic; BH3 only 3.7 3.5 2.5 3.4
Fas Extrinsic; receptor 4.3 3.1 3.4 7.4
Fas ligand Extrinsic; receptor ligand 2.4 2.1 NS 3.4
TRAIL Extrinsic; receptor ligand 4.6 3.6 NS 4.2
A20 Extrinsic; anti-apoptotic 2.3 NS 2.5 7.4
c-Flip Extrinsic; anti-apoptotic 2.6 NS NS 4.2
Caspase-3 Marker for apoptosis 4.5 3.2 3.2 2.3
BIRC3 Caspase inhibitor 3.2 2.4 NS 8.7
CARD8 Caspase-9 inhibitor −2.3 −2.4 −2.1 −2.3
BRAF Signaling kinase −3.7 −3.5 −2.5 NS
BFAR Anti-apoptotic; links both pathways −4.8 −3.5 −4.2 NS
CIDE-A Causes DNA fragmentation 3.2 2.4 3.8 NS
BNIP3 Autophagy Inducer 2.6 NS 5.6 NS
Human islets (2000 IEQ) were exposed to 200μM of peroxynitrite, 200μMo fH 2O2 or a mixture of cytokines (2ng/mL of IL-1β,1 0n g / m Lo fT N F - α and
1 0n g / m Lo fI F N - γ) for 24h or cultured under hypoxic conditions (1% oxygen) for 8h. The cDNA synthesized from isolated RNA was mixed with Master
Mix containing SYBR Green and distributed into 96 wells containing primers for the 84 genes associated with the apoptotic pathway. Five housekeeping
control genes and three RNA and PCR quality controls were also included. PCR analysis was carried out and the fold changes between control and
treated were calculated based on ΔCt and corrected for GAPDH expression. Results are the mean obtained from four diﬀerent batches of human islets.
NS: not signiﬁcant.
human islets exposed to oxidative stress, hypoxia and proin-
ﬂammatory cytokines. Genes in intrinsic and extrinsic path-
ways were induced in stressed islets (Table 2). For example,
Fas, fas ligand, and TRAIL, important regulators of the
extrinsic pathway, were induced (150–360%) by oxidative
stress and cytokines. Bid that links both pathways was
induced by 150–270%. The expression of CARD8, an
inhibitor of caspase-9, a marker for the intrinsic pathway of
apoptosis, was downregulated ∼50% by oxidants, hypoxia,
and cytokines. Downregulation of BRAF (60–73%), a critical
signaling kinase, suggests that these islets are likely to
be less responsive to growth factor-mediated cell survival
pathways. Caspase-3, a marker for apoptosis, is activated by
proteolytic cleavage.Inthisstudy,wealsoobservedincreased
expression of caspase-3 by all the stresses tested. CIDE-A
which causes DNA fragmentation was induced (140–280%)Experimental Diabetes Research 5
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Figure 1: Stress-induced modulation of genes in apoptosis pathway. Human islets (2000 IEQ) cultured in Miami medium were exposed
to multiple stresses including peroxynitrite (PN; 200μM), H2O2 (200μM), or a mixture of cytokines (Cyt; 2ng/mL of IL-1β,1 0n g / m Lo f
TNF-α, and 10ng/mL of IFN-γ) for 24h or cultured under hypoxic conditions (1% oxygen) for 8h. RNA was isolated from treated islets for
theRT-PCRanalysisofBFAR,CARD8,CIDE-A,andBNIP3usingTaqmanprobes.ResultsareM ±SEofexperimentswithfourindependent
batches of human islets. ∗P<0.01; ∗∗P<0.001 when compared to untreated control (Con).
by oxidative stress and hypoxia. Interestingly, activation of
a parallel cytoprotective pathway in response to stress was
evident by the induction of several genes in the antiapoptotic
pathway including, Bcl2A1, c-IAP2 (BIRC3), A20, and c-ﬂip
(CFLAR). BNIP3, an inducer of autophagy was induced by
160% and 460% by peroxynitrite and hypoxia, respectively.
Our ﬁndings from gene expression proﬁling points to the
complex nature of cell death pathway in islets exposed to
stresses associated with islet isolation and transplantation.
3.2. Modulation of Apoptosis Pathway Genes in Islets. Some
of the genes including BFAR, CARD8, CIDE-A, and BNIP3
listed before have not been reported previously in the
context of apoptosis in islets. Therefore, their induction was
further conﬁrmed by a more sensitive RT-PCR analysis using
Taqman probes. BFAR (bifunctional apoptosis regulator)
is a multidomain protein that interacts with members of
the extrinsic and intrinsic apoptosis pathways and inhibits
apoptosis. CARD8, a member of the caspase-associated
recruitment domain (CARD) family, inhibits the activation
of caspase-9. Levels of BFAR and CARD8 decreased by
35–40% when exposed to oxidative stress and by 50–70%
and when incubated under hypoxic conditions (Figure 1).
Cytokines decreased (30%) the expression of CARD8 but
not BFAR. The mRNA levels of CIDE-A, a gene that acts
downstream of caspases to mediate DNA fragmentation,
increased by 95–180% in islets exposed to oxidative stress
while cytokines did not have any eﬀect on the expression of
thisgene.TheexpressionofBNIP3whichplaysanimportant
role in mitochondrial autophagy increased in islets exposed
to peroxynitrite (92%) and hypoxia (240%).
3.3. Induction of Autophagy in MIN6 Cells. Autophagy is a
self-digestive process by which cells generate energy during
starvation and degrade damaged proteins and organelles. We
examined autophagicpathwaysinMIN6cellsculturedunder
low serum conditions by Western blot analysis. A key step
in the formation of autophagosomes is the conjugation of
LC3 (LC3-I-18kD) with phosphatidylethanolamine to form
LC3-PE (LC3-II-16kD), an important marker of autophagy.
As shown in Figure 2(a), the levels of LC3-II increased with
increasing concentrations of trehalose, particularly in low-
serum medium. The levels of ATG4, LAMP-2, and UVRAG
also increased in a similar manner. An increase in Beclin
1 was seen only at 100mM of trehalose in low-serum
medium. Exposure of β cells to the autophagy inhibitor
3-methyladenine (3MA) reduced the formation of LC3-II
in the presence of trehalose (Figure 2(b)) whereas another
inhibitor baﬁlomycin A1 (Bf) increased the accumulation
of LC3-II both under basal conditions as well as following
exposuretotrehalose(Figure2(b))becauseitinterferesatthe
late lysosomal degradation step leading to accumulation of
autophagosomes. Furthermore, induction of ER stress with
thapsigargin and tunicamycin (Calbiochem, La Jolla, CA)
led to formation LC3-II (Figure 2(c)) suggesting a crosstalk
between these two pathways.
3.4. Autophagic Preconditioning Protects Human Islets from
Hypoxia-Induced Apoptosis. Amino acid (AA) starvation
of human islets by incubation in Hank’s balanced salt
solution induced autophagy in β cells as shown (arrows)
by the punctated staining of LC3-II in insulin-positive cells
(Figure 3(a)). Autophagy can be protective under conditions6 Experimental Diabetes Research
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Figure 2: Induction of autophagy in MIN6 cells. (a) MIN6 cells grown to 60% conﬂuence were incubated in low (0.1%) serum or regular
(10%) serum medium in the presence of increasing concentrations of trehalose, an inducer of autophagy, for 24h. (b) MIN6 cells were
preincubated in the presence of 10mM of 3-methyladenine (3MA) or 100nM of baﬁlomycin A1 (Bf) for 20min followed by exposure to
100mM of trehalose for 24h. (c) ER stress was induced in MIN6 cells by culturing them in the presence of thapsigargin (Th; 100nM)
or tunicamycin (Tu; 1μg/mL) for 24h. Lysates of the treated cells ((a)–(c)) were analyzed by Western blotting for markers of autophagy.
Representative images from three independent experiments are presented.
of starvation in transplanted islets till vascularization takes
place. However, excessive autophagy is known to result in
cell death through crosstalk with apoptosis. Therefore it
becomes a dilemma from a therapeutic angle whether to
inhibitoractivateautophagyintransplantedislets.Totestthe
strategiesformodulationautophagyduringhypoxia,weused
trehalose, rapamycin, and amino acid starvation as inducers
during hypoxia. When islets were exposed to hypoxia in the
presence of autophagy inducers, there was exacerbation of
apoptosis. Activation of caspase-3 during hypoxia increased
further in the presence of trehalose (40–65%; P<0.01),
rapamycin (35%; P<0.05), and salt solution (115%;
P<0.001) (Figure 3(b)) suggesting the need for moderate
autophagy during hypoxia. Next we attempted autophagic
preconditioning before exposure to hypoxia as an alternate
strategy. A high-throughput screen of small molecules [22]
has identiﬁed among inducers of autophagy, several FDF-
approved drugs including Niguldipine, Penitrem A and
triﬂuoperazine. Therefore we screened a number of com-
poundsatdiﬀerentconcentrationsusingMIN6cellscultured
under hypoxia conditions. Based on those results, we tested
some of them in human islets by preincubation followed
by culture under hypoxic conditions. Signiﬁcant protection
(P<0.01) from hypoxia-induced apoptosis was seen with
all the compounds tested (Figure 3(c)). Niguldipine showed
that 75% decreases in active cleaved form of caspase-3
followed by penitrem (55%), triﬂuoperazine (40%), and
trehalose (35%).
3.5. Antiapoptotic Actions of MnSOD and Exendin-4 in
MIN6 Cells. MnSOD is an antioxidant enzyme that plays
an important role in scavenging free radicals generated by
oxidative stress. To determine the role of oxidative stress
in cytokine-mediated β cell apoptosis, a cDNA encoding
MnSOD-GFP chimeric protein was overexpressed in MIN6
cells followed by exposure to a mixture of cytokines (IL-
1β,T N F - α,a n dI F N - γ) for 48h. Activation of caspase-
9, a marker for the intrinsic pathway of apoptosis, and
activation of caspase 3, a general marker for apoptosis, were
examined in treated cells by immunoﬂuorescent staining.
Cytokines induced apoptosis by the intrinsic pathway in
MIN6 cells as shown by the staining for the active forms ofExperimental Diabetes Research 7
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Figure 3: Induction of autophagy in human islets. (a) Human islets were incubated for 8h in Miami medium (control) or in Hank’s
balanced salt solution for amino acid (AA) starvation. Treated islets were ﬁxed in paraformaldehyde and embedded in OCT. Frozen sections
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visualized by the punctated staining of LC3-II in β cells (arrows). (b) Human islets were cultured under normoxic or hypoxic conditions in
the absence and presence of inducers of autophagy, trehalose, rapamycin (Rapa) or salt solution (Salt) for 8h. Cell lysates were processed
for Western blot analysis of the active form of caspase-3. Induction of autophagy during hypoxia exacerbated apoptosis in islets. (c) Human
isletswerepreincubatedwithinducersofautophagyfor4h.Followingchangeofmedium,thecellswereculturedundernormoxicorhypoxic
conditions for 12h, lysed and processed for the Western blot analysis of active caspase-3. Autophagic preconditioning protected islets from
hypoxia-induced apoptosis. Representative images from experiments with three independent batches of human islets are presented.8 Experimental Diabetes Research
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Figure 4: Antiapoptotic actions of MnSOD and exendin-4 in MIN6 cells: MIN6 cells cultured on chamber slides were transfected with
cDNA encoding MnSOD-GFP chimeric protein. The transfected cells were exposed to a mixture of cytokines (2ng of IL-1β,1 0n go fT N F -
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Figure 6: Activation of JNK by cytokines. (a) MIN6 cells were incubated in the absence and presence of 20μM JNK inhibitor, SP600125
and/or a combination of cytokines, IL-1β (2ng/mL) TNF-α (10ng/mL) and IFN-γ (10ng/mL) for the indicated time periods. The treated
cells were processed for the Western blot analysis of phosphorylated (Phos) c-jun, total c-jun, phosphorylated (Phos) JNK and total JNK.
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active renilla luciferase. A combination of plasmid mixture encoding the JNK isozymes or their vector was also included for one experiment
(b). Transfected cells were incubated in the absence and presence of a combination of cytokines and JNK inhibitor (SP600125) as indicated
for 24h followed by the assay for luciferases. Bcl-2 promoter activity was inhibited by cytokines and JNK isozymes. Cytokine action on bcl-2
promoter activity was blocked by the JNK inhibitor. The results are M ± SE of 4 independent experiments. ∗P<0.01; ∗∗P<0.001 versus
untreated control.
caspase-9 (Figure 4(a)) and caspase-3 (Figure 4(b))w i t hc y 3
(red). MnSOD-expressing cells were identiﬁed by the green
ﬂuorescence. Staining for active caspase-9 and -3 did not
colocalizewithMnSOD-GFP-expressingcellssuggestingthat
these cells are protected from cytokine-induced apoptosis.
At least 1000 GFP-expressing cells were examined for each
experiment. We also tested the cytoprotective action of
exendin-4, a glucagon-like peptide- (GLP-1) analogue, in
MIN6 cells following induction of ER stress. Exposure of
MIN6 cells to thapsigargin and tunicamycin, inducers of ER
stress, caused apoptosis as shown by 135–180% (P<0.001)
increases in the levels of active caspase-3 (Figure 4(c)).
Preincubation of MIN6 cells with exendin-4 resulted in
signiﬁcant (P<0.01) protection with 40% decrease in the
activation of caspase-3.
3.6. Cytokine-Generated Ceramides Interfere with Activation
of Akt and CREB. Ceramides generated by cytokines are
known to decrease Akt phosphorylation [23]. Akt plays a
signiﬁcant role in CREB phosphorylation and activation,
leading to improved cell survival [24]. Therefore, human
islets were exposed to 10μM of synthetic ceramide (C2)
and the active phosphorylated form of Akt was immunoﬂu-
orescently stained with Cy3 (red) along with staining forExperimental Diabetes Research 11
insulin with FITC (green). Treatment with C2 resulted in
decrease in the levels of active form of Akt (Figure 5(a)).
Western blot analysis of human islets treated with C2 or a
combination of IL-1β,T N F - α,a n dI F N - γ showed 40–55%
decrease in PCREB, the active phosphorylated form of CREB
(Figure 5(b)). There was also a modest decrease (P<0.05)
in CREB levels in cytokine-treated islets. The activity of
CRE-site containing bcl-2 promoter was also inhibited in a
dose-dependentmannerbyC2whereastheinactiveanalogue
(dh C-2) did not aﬀect the reporter activity (Figure 5(c)).
We have previously reported similar downregulation of bcl-
2 promoter by cytokines [25]. Thus a synthetic ceramide
mimics the action of cytokines on β cell apoptosis.
3.7. Activation of JNK Pathway by Cytokines Plays a Role
in Downregulation of Bcl-2 Promoter Activity. Cytokines
strongly stimulate the signaling pathways leading to JNK
activation. JNK-mediated activation of the transcription
factor c-jun plays a critical role in inducing stress-associated
genes in β cells [26]. A combination of cytokines strongly
increased the active phosphorylated forms of JNK isozymes
with the peak activation (P<0.001) being observed at
30min (Figure 6(a)). The levels of total JNK remained the
same during the 6h incubation period. Activation of JNK
led to increases in the active phosphorylated form of c-jun.
Maximum activation (370%) was seen at 1h. The levels
of c-jun also increased (110–235%) during 6h exposure
to cytokines as it is an autoregulated gene. Preincubation
with the JNK inhibitor resulted in signiﬁcant (P<0.01)
decreases in the phosphorylation of c-jun and in the levels
of c-jun. As SP600125 also acts on kinases upstream of JNK,
the phosphorylation of JNK itself was reduced. The bcl-2
promoter activity was inhibited when a combination of JNK
isozymes was also expressed (Figure 6(b)). Cytokines further
enhanced the downregulation of bcl-2 promoter activity by
JNKisozymeswhereasJNKinhibitorblockedcytokineaction
on bcl-2 promoter (Figure 6(c)).
4. Discussion
Oxidative stress is known to play an important role in β
cell death in diabetes and in transplanted islets. Autophagy
is a physiological mechanism that protects β cells under
conditions of starvation and hypoxia. However, excessive
autophagy resulting from oxidative stress can lead to β cell
death by crosstalk with apoptosis pathway. In this study, we
report the complex modulation of apoptosis pathway genes
in human islets exposed to oxidative stress, hypoxia, and
cytokines suggesting interactions between pathways involved
i nc e l ld e a t ha sw e l la sc e l ls u r v i v a l .W ed e m o n s t r a t et h a t
autophagic preconditioning of human islets leads to protec-
tionagainsthypoxia-inducedapoptosis.InducersofERstress
were also found to activate autophagy and apoptosis in β
cells.
Pathway-speciﬁc, PCR-based arrays represent a novel
technique to determine the expression of a family of genes
associated with a speciﬁc pathway. We examined the expres-
sion of apoptosis pathway genes in human islets exposed
to multiple stresses associated with diabetes, islet isolation,
and transplantation. We observed signiﬁcant increases in the
expression of genes that are involved in opposing pathways
of cell survival and cell death. It is also important to mention
four genes, namely BFAR, CARD8, CIDE-A, and BNIP3, as
theirroleinβcellapoptosishasnotbeenreportedpreviously.
BFAR is a multidomain protein that improves cell survival
by interacting with members of extrinsic and intrinsic path-
ways of apoptosis. Caspase-associated recruitment domain
(CARD) family of proteins participates in the activation
or inhibition of caspases. CARD8 inhibits the activation of
caspase-9. The levels of both BFAR and CARD8 decreased
signiﬁcantly in islets exposed to oxidative stress and hypoxia,
suggestingadecreaseinantiapoptoticdefenseinislets.Levels
of CIDE-A, a gene that acts downstream of caspases to
mediate DNA fragmentation, increased 2- to 3-folds in
islets exposed to stress, suggesting late stages of apoptosis.
The expression of BNIP3 which plays an important role in
autophagy by disrupting the interaction between Beclin 1
and Bcl-2 was induced by peroxynitrite and hypoxia. BNIP3
promotes mitochondrial autophagy as an adaptive response
to hypoxia [27].
Several studies have reported signiﬁcant interactions
between the pathways of apoptosis and autophagy [12, 28,
29]. Apoptosis and autophagy could act as partners to
induce cell death. For example, death-associated protein
kinase (DAPK) family members, activated by cytokines, are
involved in cell death by apoptosis as well as autophagy
[12]. Conjugation of ATG5 with ATG12 is an important
step in the formation of autophagosomes during basal
autophagy. However, when there is excessive autophagy,
ATG5 has been reported to interact with components of
pathways of apoptosis. Calpain cleaves ATG5 to generate
a truncated form of this protein which translocates to
mitochondria and induces the release of cytochrome c
from mitochondria to activate the intrinsic pathway. The
antiapoptotic proteins Bcl-2 and Bcl-xL bind and inhibit
Beclin 1-mediated autophagy [30]. This interaction results
in the inhibition of autophagy because Beclin 1 will not be
able to bind to class III PI 3-kinase (VPS34) and UVRAG,
an important step in the initiation of autophagosome
formation. Essentially, Bcl-2 keeps autophagy under control
(Figure7).WehavedemonstratedpreviouslythatBcl-2levels
are regulated by CREB [25]. Therefore, under conditions
of CREB downregulation, the pathway of autophagy can be
dysregulated. In addition, JNK1-mediated phosphorylation
of Bcl-2 also results in the disruption of its interaction
with Beclin 1, leading to activation of autophagy [31]. Thus
physiological autophagy which improves cell survival can
become uncontrolled when β cells are exposed to oxidative
stress and cytokines.
Autophagy is beneﬁcial to islets in the transplantation
setting because it clears organelles damaged by oxidative
stress generated during islet isolation and provides energy
during starvation (hypoxia). Immediately after transplan-
tation, islets are exposed to hypoxia due to delayed revas-
cularization, leading to a decreased supply of nutrients to
β cells at the islet core. However, we did not observe pro-
tection of islets when autophagy was induced by trehalose,12 Experimental Diabetes Research
AMPK
ATP
JNK
mTOR
Bcl-2-P
Autophagic 
vacuolization
Bcl-2
Beclin-1
Class III PI 3-K
UVRAG
Class I PI 3-K
Fusion with 
lysosomes
Degradation
Elongation
PE 3 methyladenine
CREB
Rapamycin
ER stress
Oxidative stress
Cytokines
ATG5
ATG12
ATG7
ATG10
ATG7
ATG4
ATG3
ATG12-ATG5
ATG12-ATG5
conjugation
LC3-II
formation
LC3-I
LC3
LC3-II Baﬁlomycin A1
LAMP-2
P70SK-P
Figure 7: Interactions of signaling by ER stress, oxidative stress, and cytokines with the pathways of autophagy: Induction of autophagy
requires the assembly of Beclin-1 with class III PI 3 kinase (Vps34) and UVRAG. Rapamycin is an activator of autophagy as it is negatively
regulatedbyclassIPI3kinasethroughmammalintargetofrapamycin(mTOR).Theelongationstepinvolvestwoubiquitin-likeconjugation
system. ATG12 is activated by E1-like ATG7, transferred to E2-like ATG10 and conjugated to ATG5. Similarly, LC3-I is activated by E1-like
ATG7, transferred to E2-like ATG3, and conjugated to phosphatidylethanolamine (PE). Inhibitors of autophagy include 3 methyl adenine
which inhibits class III PI 3-K and baﬁlomycin A1 which inhibits the formation of autophagolysosome. Interaction of Bcl-2 with Beclin-1
keeps the autophagic pathway under control. CREB induces the expression of Bcl-2 which is downregulated by ER stress, oxidative stress and
cytokines through JNK.
rapamycin and salt solution during hypoxia (Figure 3(b)).
Next, we attempted an autophagic preconditioning experi-
ment with the inclusion of other new inducers. There was
indeed signiﬁcant protection in these cells when exposed to
hypoxia as shown by decrease in the activation of caspase-
3 (Figure 3(c)). Especially, FDA-approved drugs including
niguldipine and penitrem A showed signiﬁcant protection.
Islets immediately following isolation are likely to display
defects in the autophagic machinery and are likely to
succumbtohypoxia-inducedcelldeathaftertransplantation.
Thus, there is a need to restore the normal autophagic
pathway in cultured islets before transplantation. Current
understanding in the islet transplantation ﬁeld is that it is
desirable to culture islets for 24–72h before transplantation
since islets can recover from isolation-induced stress and
immunogenicity of the islets is reduced. This culture period
could also be used to assess and manipulate autophagic
pathway to improve transplantation outcome.
The pancreatic β cells are particularly vulnerable to
oxidative stress-induced injury due to low-level expression
of antioxidant enzymes [32, 33]. Markers of oxidative stress
and cellular fragility (RBC) have been shown to be elevated
in nondiabetic relatives of type 1 diabetic patients [34]. It
has been reported that β cell apoptosis could be signiﬁcantly
reduced in NOD mice, an autoimmune diabetic animal
model, after administration of an MnSOD mimetic that
is known to scavenge free radicals [35]. Proinﬂammatory
cytokines induce the expression of iNOS through NF-κBa n d
GAS sites in iNOS promoter leading to the generation of
nitric oxide [36]. When nitric oxide combines with super-
oxide generated by macrophages or cytokines, highly toxic
peroxynitriteisgenerated.Severalstudieshavedemonstrated
that peroxynitrite is an important mediator of cytokine-
induced β cell death in type 1 diabetes [37–39]. In addition,
ceramide is known to be one of the mediators of cytokine
action. The decrease of active form of Akt by ceramides can
interfere with growth factor action on CREB. We observed
that peroxynitrite and C2, a synthetic ceramide, mimic
cytokine-induced apoptosis pathway (Table 1 and Figure 5).
Although CREB elicits antiapoptotic pathways in β cells,
its function can be impaired by other transcription factors in
diabetes. For example, JNK and its nuclear target, c-jun, have
been shown to be mediators of β cell-death. JNK-activated
c-jun induces the expression of stress-associated genes [40].
Cytokines strongly stimulate the signaling pathways leading
to JNK activation [26]. Cell-permeable peptide inhibitors of
JNK block cytokine-induced β cell death [41]. Inhibition of
JNK is being considered as an important strategy to improve
β cell survival. We have reported that SP600125, a JNK
inhibitor, activates CREB [42].
ER stress is known to interact with the pathways of apop-
tosis and autophagy. For example, Islet amyloid polypeptide
(IAPP) which is colocalized and secreted with insulin from
β cell granules [43] induces β cell apoptosis in cultured
islets and in type 2 diabetes [44–46]. ER stress is the main
mechanism through which IAPP aggregates cause β cell
apoptosis [47, 48]. Silencing of IAPP with siRNA improves
the survival of cultured human islets [49]. ER stress is also a
potent inducer of autophagy [50, 51]. It has been suggested
thatautophagymight represent aprotective cellularresponse
under conditions of ER stress [52]. We observed formation
of LC3-II, a marker for autophagy in MIN6 cells following
induction of ER stress with thapsigargin and tunicamycin
(Figure 2(c)). ER stress inducers also activated caspase-
3 which was signiﬁcantly reduced by exendin-4, a GLP-1
analogue (Figure 4(c)).
It this study, we demonstrate that multiple stresses,
generated during islet isolation and transplantation, induce
β cell death by orchestration of gene expression patterns inExperimental Diabetes Research 13
apoptosis pathway. Although a parallel cell survival path-
way is also activated, it is overwhelmed by stress-induced
proapoptotic genes. Autophagy, a physiological cytopro-
tective pathway, interacts with apoptosis when induced in
excessin the islet transplantation setting. Therefore,multiple
approaches are needed to improve islet transplantation
outcome.
Acknowledgments
This work was carried out with the use of resources
and facilities at Denver VA Medical Center. The authors
thank Integrated Islet Distribution Program and Islet Cell
Resource Centers for providing human islets. This study was
supported by a Merit Review grant (NEUD-004-07F) from
the Veterans Administration and a Grant from American
Diabetes Association (1-06-JF-40) to S. Pugazhenthi.
References
[1] A. Ashkenazi and V. M. Dixit, “Death receptors: signaling and
modulation,” Science, vol. 281, no. 5381, pp. 1305–1308, 1998.
[2] D. R. Green and J. C. Reed, “Mitochondria and apoptosis,”
Science, vol. 281, no. 5381, pp. 1309–1312, 1998.
[3] T.Mandrup-Poulsen,“β-cellapoptosis:stimuliandsignaling,”
Diabetes, vol. 50, supplement 1, pp. S58–S63, 2001.
[4] S. Nagata, “Fas and Fas ligand: a death factor and its receptor,”
Advances in Immunology, vol. 57, pp. 129–144, 1994.
[5] M. Moriwaki, N. Itoh, J. Miyagawa et al., “Fas and Fas ligand
expression in inﬂamed islets in pancreas sections of patients
with recent-onset type I diabetes mellitus,” Diabetologia, vol.
42, no. 11, pp. 1332–1340, 1999.
[ 6 ]D .E .M e r r ya n dS .J .K o r s m e y e r ,“ B c l - 2g e n ef a m i l yi nt h e
nervous system,” Annual Review of Neuroscience, vol. 20, pp.
245–257, 1997.
[7] S. Ramachandran, N. M. Desai, T. A. Goers et al., “Improved
islet yields from pancreas preserved in perﬂurocarbon is via
inhibition of apoptosis mediated by mitochondrial pathway,”
American Journal of Transplantation, vol. 6, no. 7, pp. 1696–
1703, 2006.
[8] D. C. S. Huang and A. Strasser, “BH3-only proteins—essential
initiatorsofapoptoticcelldeath,” Cell,vol.103,no.6,pp.839–
842, 2000.
[9] S. N. Willis and J. M. Adams, “Life in the balance: how
BH3-only proteins induce apoptosis,” Current Opinion in Cell
Biology, vol. 17, no. 6, pp. 617–625, 2005.
[10] X. Luo, I. Budihardjo, H. Zou, C. Slaughter, and X. Wang,
“Bid,aBcl2interactingprotein,mediatescytochromecrelease
from mitochondria in response to activation of cell surface
death receptors,” Cell, vol. 94, no. 4, pp. 481–490, 1998.
[11] R. Scherz-Shouval and Z. Elazar, “ROS, mitochondria and the
regulation of autophagy,” Trends in Cell Biology, vol. 17, no. 9,
pp. 422–427, 2007.
[12] M. C. Maiuri, E. Zalckvar, A. Kimchi, and G. Kroemer,
“Self-eating and self-killing: crosstalk between autophagy and
apoptosis,” Nature Reviews Molecular Cell Biology, vol. 8, no.
9, pp. 741–752, 2007.
[13] B. J. Marsh, C. Soden, C. Alarcon et al., “Regulated autophagy
controls hormone content in secretory-deﬁcient pancreatic
endocrine β-cells,” Molecular Endocrinology, vol. 21, no. 9, pp.
2255–2269, 2007.
[14] Y. Uchizono, C. Alarcon, B. L. Wicksteed, B. J. Marsh, and
C. J. Rhodes, “The balance between proinsulin biosynthesis
and insulin secretion: where can imbalance lead?” Diabetes,
ObesityandMetabolism,vol.9,supplement2,pp.56–66,2007.
[15] N. A. Kaniuk, M. Kiraly, H. Bates, M. Vranic, A. Volchuk,
and J. H. Brumell, “Ubiquitinated-protein aggregates form in
pancreaticβ-cellsduringdiabetes-inducedoxidativestressand
are regulated by autophagy,” Diabetes, vol. 56, no. 4, pp. 930–
939, 2007.
[16] A. M. Davalli, L. Scaglia, D. H. Zangen, J. Hollister, S. Bonner-
Weir, and G. C. Weir, “Vulnerability of islets in the immediate
posttransplantation period: dynamic changes in structure and
function,” Diabetes, vol. 45, no. 9, pp. 1161–1167, 1996.
[17] G. Mattsson, L. Jansson, and P. O. Carlsson, “Decreased vas-
cular density in mouse pancreatic islets after transplantation,”
Diabetes, vol. 51, no. 5, pp. 1362–1366, 2002.
[18] B. Vasir, P. Reitz, G. Xu, A. Sharma, S. Bonner-Weir, and G.
C. Weir, “Eﬀects of diabetes and hypoxia on gene markers
of angiogenesis (HGF, cMET, uPA and uPAR, TGF-α,T G F - β,
bFGF and Vimentin) in cultured and transplanted rat islets,”
Diabetologia, vol. 43, no. 6, pp. 763–772, 2000.
[19] J. I. Miyazaki, K. Araki, E. Yamato et al., “Establishment
of a pancreatic β cell line that retains glucose-inducible
insulin secretion: special reference to expression of glucose
transporter isoforms,” Endocrinology, vol. 127, no. 1, pp. 126–
132, 1990.
[20] M. M. Bradford, “A rapid and sensitive method for the quan-
titation of microgram quantities of protein utilizing the
principle of protein dye binding,” Analytical Biochemistry, vol.
72, no. 1-2, pp. 248–254, 1976.
[21] S. Pugazhenthi, L. Akhov, G. Selvaraj, M. Wang, and J. Alam,
“Regulation of heme oxygenase-1 expression by demethoxy
curcuminoids through Nrf2 by a PI3-kinase/Akt-mediated
pathwayinmouseβ-cells,”AmericanJournalofPhysiology,vol.
293, no. 3, pp. E645–E655, 2007.
[22] L. Zhang, J. Yu, H. Pan et al., “Small molecule regulators
of autophagy identiﬁed by an image-based high-throughput
screen,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 104, no. 48, pp. 19023–19028,
2007.
[23] H. Zhou, S. A. Summers, M. J. Birnbaum, and R. N. Pittman,
“Inhibition of Akt kinase by cell-permeable ceramide and
its implications for ceramide-induced apoptosis,” Journal of
Biological Chemistry, vol. 273, no. 26, pp. 16568–16575, 1998.
[24] S. Pugazhenthit, A. Nesterova, C. Sable et al., “Akt/protein
kinase B up-regulates Bcl-2 expression through cAMP-
response element-binding protein,” Journal of Biological
Chemistry, vol. 275, no. 15, pp. 10761–10766, 2000.
[25] P. Jambal, S. Masterson, A. Nesterova et al., “Cytokine-
mediated down-regulation of the transcription factor cAMP-
response element-binding protein in pancreatic β-cells,” Jour-
nal of Biological Chemistry, vol. 278, no. 25, pp. 23055–23065,
2003.
[26] A. Ammendrup, A. Maillard, K. Nielsen et al., “The c-Jun
amino-terminal kinase pathway is preferentially activated
by interleukin-1 and controls apoptosis in diﬀerentiating
pancreatic β-cells,” Diabetes, vol. 49, no. 9, pp. 1468–1476,
2000.
[27] H. Zhang, M. Bosch-Marce, L. A. Shimoda et al., “Mitochon-
drial autophagy is an HIF-1-dependent adaptive metabolic
response to hypoxia,” Journal of Biological Chemistry, vol. 283,
no. 16, pp. 10892–10903, 2008.14 Experimental Diabetes Research
[28] A. Thorburn, “Apoptosis and autophagy: regulatory connec-
tions between two supposedly diﬀerent processes,” Apoptosis,
vol. 13, no. 1, pp. 1–9, 2008.
[29] A. L. Edinger and C. B. Thompson, “Death by design:
apoptosis, necrosis and autophagy,” Current Opinion in Cell
Biology, vol. 16, no. 6, pp. 663–669, 2004.
[30] M. C. Maiuri, G. Le Toumelin, A. Criollo et al., “Functional
a n dp h y s i c a li n t e r a c t i o nb e t w e e nB c l - X La n daB H 3 - l i k e
domain in Beclin-1,” EMBO Journal, vol. 26, no. 10, pp. 2527–
2539, 2007.
[31] Y. Wei, S. Pattingre, S. Sinha, M. Bassik, and B. Levine, “JNK1-
mediated phosphorylation of Bcl-2 regulates starvation-
induced autophagy,” Molecular Cell, vol. 30, no. 6, pp. 678–
688, 2008.
[32] A. P. Robertson, “Chronic oxidative stress as a central
mechanism for glucose toxicity in pancreatic islet beta cells in
diabetes,” Journal of Biological Chemistry, vol. 279, no. 41, pp.
42351–42354, 2004.
[33] M. Tiedge, S. Lortz, J. Drinkgern, and S. Lenzen, “Relation
between antioxidant enzyme gene expression and antioxida-
tive defense status of insulin-producing cells,” Diabetes, vol.
46, no. 11, pp. 1733–1742, 1997.
[34] E. Matteucci and O. Giampietro, “Oxidative stress in families
of type 1 diabetic patients,” Diabetes Care, vol. 23, no. 8, pp.
1182–1186, 2000.
[ 3 5 ] K .H a s k i n s ,J .K e n c h ,K .P o w e r seta l . ,“ R o l ef o ro x i d a ti v es tr e s s
in the regeneration of islet beta cells?” Journal of Investigative
Medicine, vol. 52, no. 1, pp. 45–49, 2004.
[36] M.I.DarvilleandD.L.Eizirik,“Regulationbycytokinesofthe
inducible nitric oxide synthase promoter in insulin-producing
cells,” Diabetologia, vol. 41, no. 9, pp. 1101–1108, 1998.
[37] J. R. T. Lakey, W. L. Suarez-Pinzon, K. Strynadka et al.,
“Peroxynitrite is a mediator of cytokine-induced destruction
ofhumanpancreaticisletβ cells,”LaboratoryInvestigation,vol.
81, no. 12, pp. 1683–1692, 2001.
[38] W. L. Suarez-Pinzon, C. Szab´ o, and A. Rabinovitch, “Devel-
opment of autoimmune diabetes in NOD mice is associated
with the formation of peroxynitrite in pancreatic islet β-cells,”
Diabetes, vol. 46, no. 5, pp. 907–911, 1997.
[39] C. A. Delaney, B. Tyrberg, L. Bouwens, H. Vaghef, B. Hellman,
and D. L. Eizirik, “Sensitivity of human pancreatic islets
to peroxynitrite-induced cell dysfunction and death,” FEBS
Letters, vol. 394, no. 3, pp. 300–306, 1996.
[40] J. Ham, A. Eilers, J. Whitﬁeld, S. J. Neame, and B. Shah, “c-
Jun and the transcriptional control of neuronal apoptosis,”
BiochemicalPharmacology,vol.60,no.8,pp.1015–1021,2000.
[41] C. Bonny, A. Oberson, S. Negri, C. Sauser, and D. F.
Schorderet, “Cell-permeable peptide inhibitors of JNK. Novel
blockers of β-cell death,” Diabetes, vol. 50, no. 1, pp. 77–82,
2001.
[42] D. Vaishnav, P. Jambal, J. E. B. Reusch, and S. Pugazhenthi,
“SP600125, an inhibitor of c-jun N-terminal kinase, activates
CREB by a p38 MAPK-mediated pathway,” Biochemical and
Biophysical Research Communications, vol. 307, no. 4, pp. 855–
860, 2003.
[43] S. E. Kahn, D. A. D’Alessio, M. W. Schwartz et al., “Evidence
of cosecretion of islet amyloid polypeptide and insulin by β-
cells,” Diabetes, vol. 39, no. 5, pp. 634–638, 1990.
[44] R. A. Ritzel, J. J. Meier, C. Y. Lin, J. D. Veldhuis, and P. C.
Butler, “Human islet amyloid polypeptide oligomers disrupt
cell coupling, induce apoptosis, and impair insulin secretion
in isolated human islets,” Diabetes, vol. 56, no. 1, pp. 65–71,
2007.
[45] A. Lorenzo and B. A. Yankner, “Amyloid ﬁbril toxicity in
Alzheimer’s disease and diabetes,” Annals of the New York
Academy of Sciences, vol. 777, pp. 89–95, 1996.
[46] S. Zhang, J. Liu, M. Dragunow, and G. J. S. Cooper, “Fibril-
logenic amylin evokes Islet β-cell apoptosis through linked
activation of a caspase cascade and JNK1,” Journal of Biological
Chemistry, vol. 278, no. 52, pp. 52810–52819, 2003.
[47] C. J. Huang, L. Haataja, T. Gurlo et al., “Induction of
en-doplasmic reticulum stress-induced β-cell apoptosis and
accumulation of polyubiquitinated proteins by human islet
amyloidpolypeptide,”AmericanJournalofPhysiology,vol.293,
no. 6, pp. E1656–E1662, 2007.
[48] C. J. Huang, C. Y. Lin, L. Haataja et al., “High expression
rates of human islet amyloid polypeptide induce endoplasmic
reticulum stress-mediated β-cell apoptosis, a characteristic of
humans with type 2 but not type 1 diabetes,” Diabetes, vol. 56,
no. 8, pp. 2016–2027, 2007.
[49] L. Marzban, A. Tomas, T. C. Becker et al., “Small interfering
RNA-mediated suppression of proislet amyloid polypeptide
expression inhibits islet amyloid formation and enhances
survival of human islets in culture,” Diabetes, vol. 57, no. 11,
pp. 3045–3055, 2008.
[50] K. Sakaki, J. Wu, and R. J. Kaufman, “Protein kinase Cθ
is required for autophagy in response to stress in the
endoplasmic reticulum,” Journal of Biological Chemistry, vol.
283, no. 22, pp. 15370–15380, 2008.
[51] M. Hoyer-Hansen and M. Jaattela, “Connecting endoplasmic
reticulum stress to autophagy by unfolded protein response
and calcium,” Cell Death and Diﬀerentiation,v o l .1 4 ,n o .9 ,p p .
1576–1582, 2007.
[52] M. Ogata, S. I. Hino, A. Saito et al., “Autophagy is activated
for cell survival after endoplasmic reticulum stress,” Molecular
and Cellular Biology, vol. 26, no. 24, pp. 9220–9231, 2006.